Santori & Peters, Inc. Amgen Inc Transaction History

Santori & Peters, Inc.

$251 Million
Q3 2024

A detailed history of Santori & Peters, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Santori & Peters, Inc. holds 1,949 shares of AMGN stock, worth $513,327. This represents 0.25% of its overall portfolio holdings.

Number of Shares

1,949

Previous 1,949 -0.0%

Holding current value

$513,327

Previous $608,000 3.13%

% of portfolio

0.25%

Previous 0.26%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	SELL	$262.75 - $319.31 $3,153 - $3,831	-12 Reduced 0.61%	1,949 $608,000
Q1 2024 Apr 19, 2024	BUY	$268.87 - $324.56 $4,033 - $4,868	15 Added 0.77%	1,961 $557,000
Q4 2023 Feb 05, 2024	BUY	$255.7 - $288.46 $3,579 - $4,038	14 Added 0.72%	1,946 $560,000
Q3 2023 Nov 03, 2023	BUY	$218.65 - $271.46 $3,061 - $3,800	14 Added 0.73%	1,932 $519,000
Q2 2023 Jul 26, 2023	BUY	$214.27 - $253.37 $3,642 - $4,307	17 Added 0.89%	1,918 $425,000
Q1 2023 Apr 19, 2023	BUY	$225.79 - $275.2 $3,612 - $4,403	16 Added 0.85%	1,901 $459,000
Q4 2022 Jan 26, 2023	BUY	$229.03 - $291.01 $2,748 - $3,492	12 Added 0.64%	1,885 $0
Q3 2022 Oct 14, 2022	BUY	$224.46 - $253.15 $3,142 - $3,544	14 Added 0.75%	1,873 $422,000
Q2 2022 Jul 13, 2022	BUY	$230.71 - $256.74 $2,999 - $3,337	13 Added 0.7%	1,859 $452,000
Q1 2022 Apr 28, 2022	BUY	$219.27 - $242.57 $3,069 - $3,395	14 Added 0.76%	1,846 $446,000
Q4 2021 Jan 14, 2022	BUY	$198.88 - $227.6 $2,784 - $3,186	14 Added 0.77%	1,832 $412,000
Q3 2021 Oct 22, 2021	BUY	$212.27 - $248.7 $2,759 - $3,233	13 Added 0.72%	1,818 $386,000
Q2 2021 Jul 21, 2021	BUY	$233.58 - $259.14 $2,802 - $3,109	12 Added 0.67%	1,805 $440,000
Q1 2021 Apr 28, 2021	BUY	$221.91 - $258.6 $2,662 - $3,103	12 Added 0.67%	1,793 $446,000
Q4 2020 Jan 13, 2021	SELL	$216.38 - $257.67 $4,327 - $5,153	-20 Reduced 1.11%	1,781 $424,000
Q3 2020 Oct 16, 2020	BUY	$234.65 - $260.95 $11,732 - $13,047	50 Added 2.86%	1,801 $201,000
Q2 2020 Jul 07, 2020	BUY	$197.81 - $242.74 $2,175 - $2,670	11 Added 0.63%	1,751 $413,000
Q1 2020 Apr 27, 2020	BUY	$182.24 - $241.7 $2,369 - $3,142	13 Added 0.75%	1,740 $352,000
Q4 2019 Jan 09, 2020	BUY	$189.21 - $243.2 $1,892 - $2,432	10 Added 0.58%	1,727 $416,000
Q3 2019 Oct 15, 2019	BUY	$174.11 - $208.62 $1,915 - $2,294	11 Added 0.64%	1,717 $332,000
Q2 2019 Jul 30, 2019	BUY	$166.7 - $195.41 $2,167 - $2,540	13 Added 0.77%	1,706 $314,000
Q1 2019 Apr 30, 2019	BUY	$180.87 - $203.88 $2,170 - $2,446	12 Added 0.71%	1,693 $321,000
Q4 2018 Feb 06, 2019	BUY	$178.4 - $208.25 $1,784 - $2,082	10 Added 0.6%	1,681 $327,000
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $282,048 - $315,133	1,671	1,671 $289,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Santori & Peters, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Santori & Peters, Inc. with notifications on news.

Account

Santori & Peters, Inc. Amgen Inc Transaction History